Tag Archive for: ATMP

Astraveus CEO Jérémie Laurant. © Astraveus

French cell and gene therapy manufacturing specialist Astraveus SAS had raises €16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.

Ospedale San Raffale in Milan. © Mystère Martin/wikimedia

Italian researchers have successfully ameliorated several IL-1-based autoimmune disorders by gene therapy into transplantable hematopoietic stem cells of mice.

© eXmoor Pharma Concepts Ltd

Bristol-based eXmoor Pharma Ltd has completed a US$35m Series A financing to expand its cell and gene therapy manufacturing capabilities.

Cancer cell © peterschreiber. media - stock.ado

CDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences.

Tag Archive for: ATMP

PharmaLab2025_ebm-event-highlight

Last year, potency assays as a new conference topic was very well received by attendees. It will therefore be offered again this year. Further, according to the general feedback, there is also a need for conferences on other topics as a platform for exchanging experiences and opinions with colleagues and regulatory representatives. Accordingly, in 2025, three new topics will be addressed in dedicated tracks:

• Bioanalytical Control of Biological Drug Substances and Products
• Quality Control of mRNA/LNP Products (Pre-Conference, 24 November)
• Artificial Intelligence in Laboratories

The established topics will also be covered at PharmaLab 2025 from 24-26 November in Neuss – providing participants with the opportunity to exchange knowledge and experiences with representatives from authorities like EDQM, PEI, NIBSC/MHRA, AGES, industrial experts and scientists from laboratories:

• Analytical Quality and Lifecycle Concepts
• GMP Compliance Trends Analytical Laboratories
• Laboratory Optimization, Automation and Digitalization/Outsourcing in Pharmaceutical Laboratories
• Endotoxin and Pyrogen Testing
• Alternative and Rapid Microbiological Methods
• Cell and Gene Therapies/ ATMPs – Quality and Safety
• Bioassays/Potency Assays – Regulatory Requirements, Developments and Routine Use
• 6th International Mycoplasma qPCR Testing User Day (Pre-Conference, 24 November)

Congress delegates benefit from 9 parallel conferences, 2 pre-conference workshops with altogether over 100 presentations, 50 exhibitors in the exhibition and the networking event. An update in all relevant areas of pharmaceutical lab developments will be provided.

One-day and multi-day tickets offer participants the opportunity to attend parts or even the entire congress and thereby put together an individual programme with the lectures of choice.

More information

Website: https://www.pharmalab-congress.com

eMail: info(at)concept-heidelberg.de